Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

LON/0R1F stock hub

LON/0R1F has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0R1Fis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

84.2B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0R1F

In the news

Latest news · LON/0R1F

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.1

P25 12.9P50 16.9P75 23.5

Trailing P/E15.3

P25 15.9P50 22.9P75 35.8

ROE38.7

P25 -54.2P50 2.1P75 13.7

ROIC20.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0R1F market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

USD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	32,500
Employees Change	-200%
Employees Change Percent	-0.58
Enterprise value	$110.3B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US1101221083
Last refreshed	2026-05-10
Market cap	$84.2B
Price	$56
Price currency	USD
Rev Per Employee	1,129,712.65x
Sector	Healthcare
Sic	2834
Symbol	lon/0R1F
Website	https://www.bms.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.55%
EV Earnings	20.02x
EV/EBIT	9.77x
EV/EBITDA	7.75x
EV/FCF	12.23x
EV/Sales	3.1x
FCF yield	10.71%
Forward P/E	9.08x
P/B ratio	5.53x
P/E ratio	15.28x
P/S ratio	2.29x
PE Ratio10 Y	39.48x
PE Ratio3 Y	16.73x
PE Ratio5 Y	19.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	31.56%
EBITDA Margin	39.14%
FCF margin	24.56%
Gross margin	71.98%
Gross Profit	$26.4B
Gross Profit Growth	-1.91%
Gross Profit Growth Q	-1.25%
Gross Profit Growth3 Y	-1.01%
Gross Profit Growth5 Y	0.44%
Net Income	$5.5B
Net Income Growth	34.25%
Net Income Growth Q	9%
Net Income Growth3 Y	-0.16%
Pretax Margin	19.79%
Profit Margin	15.01%
Profit Per Employee	$169,520
ROA	10.69
Roa5y	6.51
ROCE	22.73
ROE	38.73
Roe5y	13.18
ROIC	20.88
Roic5y	14.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	24.11%
Cagr3y	-1.37%
Cagr5y	1.24%
Div CAGR3	-0.13%
Div CAGR5	5.45%
EPS Growth	33.74
EPS Growth Q	9.17
EPS Growth3 Y	1.37
FCF Growth	-9%
FCF Growth Q	-55.31%
FCF Growth3 Y	2.43%
FCF Growth5 Y	-2.04%
OCF Growth	-7.02%
OCF Growth Q	-43.5%
OCF Growth10 Y	29.83%
OCF Growth3 Y	2.87%
OCF Growth5 Y	-0.93%
Revenue Growth	1.78x
Revenue Growth Q	2.57x
Revenue Growth Quarters	2x
Revenue Growth3 Y	1.88x
Revenue Growth5 Y	2.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.54
Assets	$65.5B
Cash	$7.9B
Current Assets	$20B
Current Liabilities	$14.1B
Debt	$35.2B
Debt EBITDA	$2.4
Debt Equity	$2.31
Debt FCF	$3.9
Equity	$15.2B
Interest Coverage	8.48
Liabilities	$50.3B
Long Term Assets	$45.5B
Long Term Liabilities	$36.2B
Net Cash	$-26.9B
Net Cash By Market Cap	$-32.01
Net Debt EBITDA	$1.88
Net Debt Equity	$1.77
Net Debt FCF	$2.99
Tangible Book Value	$-15.1B
Tangible Book Value Per Share	$-7.39
WACC	4.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.42
Inventory Turnover	5.01
Net Working Capital	$53.8M
Quick ratio	1.18
Working Capital	$6.1B
Working Capital Turnover	$4.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.47%
Dividend Growth	-2.56%
Dividend Growth Years	4%
Dividend per share	$1.86
Dividend Years	10
Dividend Yield	3.32%
Ex Div Date	2026-04-02
Last Dividend	$0.48
Payout Frequency	Quarterly
Payout Ratio	69.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	24.09%
200-day SMA	52.26
3Y total return	-4.06%
50-day SMA	59.17
50-day SMA vs 200-day SMA	50over200
5Y total return	6.35%
All Time High	81.4
All Time High Change	-31.2%
All Time High Date	2022-12-05
All Time Low	39.35
All Time Low Change	42.31%
All Time Low Date	2024-07-05
ATR	2.02
Beta	0.26
Ch YTD	3.36
High	56.96
High52	63
High52 Date	2026-03-02
High52ch	-11.11%
Low	55.46
Low52	42.54
Low52 Date	2025-10-29
Low52ch	31.64%
Ma50ch	-5.35%
Price vs 200-day SMA	7.16%
RSI	40.32
RSI Monthly	52.48
RSI Weekly	51.6
Sharpe ratio	0.83x
Sortino ratio	1.45
Total Return	2.85%
Tr YTD	5.67
Tr1m	-3.56%
Tr1w	-5.17%
Tr3m	-8.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$11.6B
Operating Income Growth	38.03
Operating Income Growth Q	7.35
Operating Income Growth3 Y	16.68
Operating Income Growth5 Y	15.03
Operating margin	31.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,038,886,888%
Net Borrowing	-4,197,167,108
Shares Insiders	0.05%
Shares Institutions	81.98%
Shares Qo Q	0.29%
Shares Yo Y	0.47%
Short Ratio	2.69

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$8.6B
Average Volume	9,959.6x
Bv Per Share	7.44
CAPEX	$-1.1B
Ch1m	-3.56
Ch1w	-5.17
Ch1y	18.17
Ch3m	-9.58
Ch3y	-16.48
Ch5y	-12.99
Ch6m	20.31
Change	-1.41%
Change From Open	-0.66
Close	56.8
Days Gap	-0.76
Depreciation Amortization	2,695,663,950
Dollar Volume	142,408
Earnings Date	2026-04-30
EBIT	$11.6B
EBITDA	$14.4B
EPS	$2.7
F Score	7
FCF	$9B
FCF EV Yield	8.18x
Financing CF	-8,265,984,075
Fiscal Year End	December
Founded	1,887
Goodwill	15,946,594,360
Graham Number	28.90435
Graham Upside	-48.39
Income Tax	$1.8B
Investing CF	-2,850,496,020
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	$18.33
Lynch Upside	-67.27
Ma150	54.21
Ma150ch	3.31%
Ma20	58.24
Ma20ch	-3.85%
Net CF	-978,438,060
Open	56.37
P FCF Ratio	9.33
P OCF Ratio	8.35
Payment Date	2026-05-01
Position In Range	36
Ppne	6,738,059,604
Price Date	2026-05-08
Price EBITDA	$5.86
Relative Volume	0.27x
Revenue	36,715,661,010x
SBC By Revenue	1.14x
Share Based Comp	420,304,275
Tax By Revenue	4.79x
Tax Rate	24.22%
Tr6m	23.01%
Volume	2,543
Z Score	2.48

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0R1F dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.3%

$1.86 annual per share

Payout ratio

+69.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.4%

4 consecutive years of growth

Total shareholder yield

+2.8%

Next ex-dividend date: 2026-04-02

Performance

LON/0R1F stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0R1F?

Insider, institutional, and short-interest positioning.

Institutional ownership

+82.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0R1F momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.3

Neutral momentum band

Price vs 200-day MA

+7.2%

50/200-day relationship not available

Beta (5Y)

0.26

Less volatile than the market

Sharpe ratio

0.83

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0R1F

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0R1F stock rating?

lon/0R1F is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0R1F analysis?

The full report lives at /stocks/lon/0R1F/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0R1F?

The latest report frames lon/0R1F around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0R1F page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.